By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-22T13:04:00Z
2026-06-15T12:35:00Z
2026-05-19T09:46:00
Contributor Dr Nitza Thomasson
2026-03-11T14:00:00
Sponsored by Merck
2026-03-25T15:00:00
Sponsored by Yokogawa
2025-04-02T14:00:00
Sponsored by Eurofins Discovery
2025-05-14T14:30:00
Sponsored by Abzena
2026-06-15T07:00:00
Contributor Professor Dipak Ramji, By Drug Target Review
Site powered by Webvision Cloud